MKI67 and breast carcinoma: Ki67% protein expression, a marker measured in most kinds of cancers and considered decisive for therapy in some, like breast cancer, has previously been correlated with a higher engraftment success rates, and has been used in a model for prediction of PDX establishment in the previous literature [53,54].